Fundz

Who to call at TNF Pharmaceuticals, and when

Fundz watches for the moments TNF Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day TNF Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at TNF Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at TNF Pharmaceuticals. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchTNF Pharmaceuticals Announces Initiation of a Study Series to Preserve Muscle Mass During Weight Loss Treatments

Jan 29, 2025
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Product Description

TNF Pharmaceuticals has launched a series of studies to evaluate the effectiveness of its novel oral TNF-alpha inhibitor drug, isomyosamine, in preserving lean muscle mass in patients undergoing GLP-1 weight loss treatments.

Company Information

Company

TNF Pharmaceuticals

Location

New York, New York, United States

About

TNF Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing novel therapies for autoimmune and inflammatory conditions. The company aims to extend healthy lifespan by treating the underlying causes of diseases rather than just their symptoms. Its drug platforms include a small molecule, isomyosamine, which regulates the immune system, and Supera-CBD, aiming to treat chronic pain, addiction, and epilepsy. TNF is committed to addressing chronic inflammation and improving patient outcomes through its innovative therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment TNF Pharmaceuticals ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Mitchell hidden

hidden
hidden
Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for TNF Pharmaceuticals's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

TNF Pharmaceuticals shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.